3.0.0 2254 2025-12-05T08:17:23Z 2025-12-05T08:17:23Z Senate S S 2023-07-12 118 https://www.congress.gov/bill/118th-congress/senate-bill/2254 ssfi00 Finance Committee Senate Standing Referred To 2023-07-12T15:00:45Z 118 2973 S 2023-12-07 Placed on Senate Legislative Calendar under General Orders. Calendar No. 266. Related bill CRS 118 5385 HR 2024-12-17 Referred to the Subcommittee on Health. Identical bill CRS 2023-07-12 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2023-07-12 Introduced in Senate IntroReferral 10000 9 Library of Congress C001113 Sen. Cortez Masto, Catherine [D-NV] Catherine Cortez Masto D NV N T000476 Sen. Tillis, Thomas [R-NC] Thomas Tillis R NC Roland 2023-07-12 True W000779 Sen. Wyden, Ron [D-OR] Ron Wyden D OR 2023-07-12 True C000880 Sen. Crapo, Mike [R-ID] Mike Crapo R ID 2023-07-12 True Health Accounting and auditing 2023-12-15T14:30:25Z Congressional oversight 2023-12-15T14:30:25Z Contracts and agency 2023-12-15T14:30:25Z Drug safety, medical device, and laboratory regulation 2023-12-15T14:30:25Z Government information and archives 2023-12-15T14:30:25Z Government studies and investigations 2023-12-15T14:30:25Z Health care costs and insurance 2023-12-15T14:30:25Z Prescription drugs 2023-12-15T14:30:25Z Retail and wholesale trades 2023-12-15T14:30:25Z Health 2023-08-07T23:45:19Z

00 2023-07-12 Introduced in Senate 2024-08-19T22:01:41Z <p><strong>Medicare PBM Accountability Act</strong></p><p>This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.</p><p>Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to&nbsp;the Centers for Medicare &amp; Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit&nbsp;PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.</p><p>In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.</p>

Display Title 45 2024-07-24T15:21:09Z Short Title(s) as Introduced 101 2024-05-24T13:37:58Z Introduced in Senate IS Official Title as Introduced 6 2023-08-04T00:58:55Z Introduced in Senate IS Introduced in Senate 2023-07-12T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s2254is/xml/BILLS-118s2254is.xml 2023-07-12 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.